© 2025 Historical Returns. All rights reserved.

Historical Returns of Dr. Reddy's Laboratories Limited

From 1996 to 2024 (28 years), the stock price grew by 11,483.18%. Dividends were issued 22 times and stock splits occurred 2 times during this period.

Find Out How Much Your Investment in Dr. Reddy's Laboratories Limited Could Have Grown.

Invested

Bought

Investment Period
Start Date
End Date
Dr. Reddy's Laboratories Limited data starting From 1, 1996

Results

Capital Growth

Between , your total capital would have grown XXXX.

Dividends

You would have earned XXXX in dividends.

Stock Splits

Your total number of shares after stock splits and bonus shares would have grown from XXXX.

Dr. Reddy's Laboratories Limited

Dr. Reddy’s Laboratories Limited is a globally renowned pharmaceutical company headquartered in India, committed to delivering high-quality and affordable healthcare solutions. Established in 1984, the company operates in over 50 countries and is a trusted name in generic medicines, active pharmaceutical ingredients (APIs), and specialty pharmaceuticals.

Dr. Reddy’s product portfolio spans a wide range of therapeutic areas, including oncology, gastroenterology, cardiovascular, and dermatology. The company is known for its innovation and excellence in developing complex generics and biosimilars to address unmet medical needs.

With a strong focus on research and development, Dr. Reddy’s continues to pioneer advanced drug delivery systems and novel therapies. The company is also dedicated to sustainability, ensuring environmentally friendly practices and contributing to community health initiatives.

Driven by the vision of ‘Good Health Can’t Wait,’ Dr. Reddy’s Laboratories Limited remains at the forefront of global healthcare, improving lives and enhancing access to affordable medicines worldwide.